...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Clinical Medicine >Medical, Technical and Audiological Outcomes of Hearing Rehabilitation with the Bonebridge Transcutaneous Bone-Conduction Implant: A Single-Center Experience
【24h】

Medical, Technical and Audiological Outcomes of Hearing Rehabilitation with the Bonebridge Transcutaneous Bone-Conduction Implant: A Single-Center Experience

机译：骨桥经皮骨传导植入物进行听力康复的医学，技术和听觉方面的成果：单中心体验

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Bone-conduction implants are a standard therapeutic option for patients with conductive, unilateral, or mixed hearing loss who either do not tolerate conventional hearing aids or can benefit from surgery. The aim of this study was to evaluate long-term medical and technical outcomes, and audiological results with the Bonebridge transcutaneous bone-conduction implant. This retrospective study included all patients implanted with a bone-conduction hearing implant at a tertiary medical referral center between March 2012 and October 2018. Medical and technical outcomes included the mean length of implant usage, medical and technical complications (skin and wound infection, lack of benefit, technical failure), explantations and revisions, coupling approaches, implant failure rate, implant survival and the implant loss for added follow-up years. Auditory results were measured by functional hearing gain and the Freiburger monosyllabic test at 65 dB sound pressure level. Sixty-four patients were included in the study; five of these were implanted bilaterally (69 devices). Five unilaterally implanted patients were lost to follow-up. The mean follow-up was 27.1 months (range: 0.2 months–6.3 years). The mean implant usage was 25.9 months (range: 0.2 months–6.3 years). Fifty-seven implants (89.1%) were in use at the end of the follow-up period. Complications occurred in six ears (9.4%). Five implants (7.8%) were explanted without reimplantation. Device failure occurred in one implant (1.6%), which was possibly caused by recurrent head trauma. The rate of implant loss due to technical device failure (damage to device) was 1 per 72 follow-up years. The mean improvement on the Freiburger monosyllabic test (52.1%, p = 0.0001), and in functional hearing gain across frequencies (26.5 dB, p = 0.0001) was significant. This single-center follow-up reveals the medical and technical reliability of a transcutaneous bone-conduction implant for hearing rehabilitation because complication and revision rates were low. The majority of patients still used the device at the end of the observation period. Implantation resulted in favorable hearing outcomes in comparison to that of unaided conditions. Cautious patient selection mainly regarding co-morbidities, the history of chronic otologic diseases and proper surgical technique seems to be crucial in reducing complications.
机译：骨传导植入物是传导性，单侧或混合性听力损失患者的标准治疗选择，这些患者要么不能忍受传统的助听器，要么可以从手术中受益。这项研究的目的是评估Bonebridge经皮骨传导植入物的长期医学和技术成果以及听力学结果。这项回顾性研究包括所有在2012年3月至2018年10月期间在三级医疗转诊中心植入骨导听力植入物的患者。医疗和技术成果包括平均使用植入物的时间，医疗和技术并发症（皮肤和伤口感染，缺乏效益，技术失败），移植和翻修，耦合方法，植入物失败率，植入物生存率以及后续随访年的植入物损失。在65 dB声压级下，通过功能性听觉增益和Freiburger单音节测试测量听觉结果。这项研究包括了64名患者。其中有五个被双边植入（69个装置）。五名单侧植入患者失访。平均随访时间为27.1个月（范围：0.2个月至6.3年）。平均植入物使用时间为25.9个月（范围：0.2个月至6.3年）。在随访期结束时使用了57个植入物（占89.1％）。六只耳朵发生并发症（9.4％）。 5颗植入物（7.8％）被植入而没有再植入。一颗植入物（1.6％）发生设备故障，这可能是由于头部反复受伤造成的。由于技术设备故障（设备损坏）导致的植入物丢失率为每72个随访年1个。 Freiburger单音节测试的平均改善（52.1％，p = 0.0001），以及整个频率的功能性听力增益的平均改善（26.5 dB，p = 0.0001）。这个单一中心的随访揭示了用于并发症的透皮骨导植入物的医学和技术可靠性，因为其并发症和翻修率很低。在观察期结束时，大多数患者仍在使用该设备。与无助的情况相比，植入可带来良好的听力效果。对患者的谨慎选择主要是关于合并症，慢性耳病的病史和适当的手术技术，这对于减少并发症至关重要。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号